Pharmacologically, GLP-1R is a G-protein coupled receptor (GPCR) critical for glucose homeostasis, which mediates the effects of GLP-1R agonists [26, 27]
A new generation of appetite-suppressing, injectable drugs called GLP-1 agonists has become immensely popular in the last few years, transforming the treatment for obesity and diabetes in many countries
( Conclusions Taking into account the limitations of this study along with the large sample size and constraints, there was a still a significant 86% risk reduction in lymphedema in the GLP-1 RA group
It also minimizes the activity of free radicals in the body, preventing the activation of melanin-producing enzymes
However, this compound is known for being an almost perfect antioxidant, due to its ability to combat oxidative stress in the body